Dr. Chadi Nabhan is joined by Stephanie Chuang, a patient advocate, non-Hodgkin lymphoma survivor, and the visionary mind behind The Patient Story, a website that shares patients’ stories and information and resources for those diagnosed with cancer.
Advertisement
RNA biomarkers are not reliant on age-related methylation patterns that may result in test performance variability.
The effects of primary tumor and LN volume on clinical outcomes in ESCC following neoadjuvant CCRT and surgery are unknown.
Drs. Cynthia Delgado and Neil R. Powe made TIME's list of the 100 most influential people in global health.
Children with high blood pressure are more likely to develop serious heart conditions, including stroke and heart attack.
Sleep alterations occur with considerable frequency in chronic stroke patients and can lead to worse outcomes.
In kidney and liver transplant recipients, steroids and mycophenolic acid were associated with COVID-19 hospitalization risk.
PRECEDE offers testing for individuals at high risk of pancreatic cancer, with multiple testing sites located globally.
Dr. Rodón Ahnert compares the differences of sacituzumab tirumotecan use in the second- vs third-line setting for patients.
DocWire Content Partners
Gain insights from The CardioNerds, a group of cardiology experts who aim to democratize cardiovascular education.
Fundamentals, core concepts, and important management approaches in the field of hematology and oncology
Dr. Chadi Nabhan, a renowned voice in hematology and oncology, tackles a multitude of relevant health care topics.
Drs. Rohit Gosain and Rahul Gosain discuss practice-changing data and standards of oncology care.
Dr. Hady Lichaa is an interventional cardiologist specializing in complex coronary interventions.
Review important issues in the rheumatology space, including lupus, rheumatoid arthritis, and more, from Dr. Maheswaranathan.
Powered by DocWire News
The Latest From GI Oncology Now
RNA biomarkers are not reliant on age-related methylation patterns that may result in test performance variability.
The effects of primary tumor and LN volume on clinical outcomes in ESCC following neoadjuvant CCRT and surgery are unknown.
PRECEDE offers testing for individuals at high risk of pancreatic cancer, with multiple testing sites located globally.
Dr. Rodón Ahnert compares the differences of sacituzumab tirumotecan use in the second- vs third-line setting for patients.
Dr. Goel discusses how his team's liquid biopsy can be used with CA19-9 to boost the accuracy of detecting pancreatic cancer.
Colorectal cancer screening intervals can potentially be extended to 15 years to avoid unnecessary invasive examinations.
The Latest From Heme Today
Phase III data from the CLIMB SCD-121 trial verified the efficacy of exa-cel in eliminating vaso-occlusive crises in SCD.
Age, weight, graft failure, and donor type are some predictors of pain crisis after HSCT in patients with SCD.
The US FDA has approved fidanacogene elaparvovec-dzkt, a gene therapy for adults with hemophilia B.
Oral and intravenous iron supplementation effectively treated restless legs syndrome in patients with iron deficiency anemia.
In the one-year, fixed-dose extension period of the ESTIMATE study, mitapivat showed continued safety and efficacy in SCD.
Etavopivat was safe and increased hemoglobin, decreased hemolysis, and improved red blood cells in patients with SCD.
